Medical Facilities Corporation (TSX: DR)

Medical Facilities Income Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	444.59	445.58	424.55	398.63	363.85	398.1
Revenue Growth (YoY)	2.67%	4.95%	6.50%	9.56%	-8.60%	1.86%
Cost of Revenue	280.39	282.94	271.28	249.93	235.45	241.42
Gross Profit	164.21	162.65	153.27	148.71	128.4	156.68
Selling, General & Admin	72.43	74	70.86	57.68	58.73	60.14
Depreciation & Amortization	20.77	21.54	20.76	26.77	27.89	29.79
Operating Expenses	93.2	95.54	91.62	84.45	86.62	89.93
Operating Income	71.01	67.11	61.65	64.26	41.79	66.76
Interest Expense	-13.68	-13.77	-12.89	-14.2	-14.35	-18.29
Interest & Investment Income	0.74	0.72	0.32	0.08	2.3	3.54
Net Interest Expenses	-12.94	-13.05	-12.57	-14.13	-12.05	-14.75
Income (Loss) On Equity Investments	-0.32	-0.32	-0.57	-0.13	-1.84	-0.1
Currency Exchange Gain (Loss)	-0.07	-0.03	-0	-0.03	-0.05	0.72
Other Non Operating Income (Expenses)	-9.53	-3.08	7.7	-12.19	-12.76	42.78
EBT Excluding Unusual Items	48.14	50.62	56.2	37.79	15.09	95.41
Impairment of Goodwill	-	-	-15.36	-	-	-22
Gain (Loss) on Sale of Assets	2.49	2.49	-	-	-	-
Asset Writedown	-	-	-1.19	-	-	-
Other Unusual Items	-0.79	-0.79	-22.15	13.1	26.69	-2.6
Pretax Income	49.84	52.32	17.5	50.89	41.78	71.71
Income Tax Expense	7.05	8.33	5.21	4.4	4.36	12.03
Earnings From Continuing Operations	42.79	44	12.3	46.49	37.42	59.68
Earnings From Discontinued Operations	-	-	-	-	-1.74	-34.26
Net Income to Company	42.79	44	12.3	46.49	35.68	25.42
Minority Interest in Earnings	-26.93	-25.5	-16.7	-30.99	-26.87	-15.6
Net Income	15.86	18.5	-4.41	15.5	8.81	9.82
Net Income to Common	15.86	18.5	-4.41	15.5	8.81	9.82
Net Income Growth	101.63%	-	-	75.88%	-10.29%	-53.06%
Shares Outstanding (Basic)	25	25	29	31	31	31
Shares Outstanding (Diluted)	25	25	29	31	31	37
Shares Change (YoY)	-15.95%	-14.00%	-5.65%	0.07%	-16.04%	11.65%
EPS (Basic)	0.64	0.73	-0.15	0.50	0.28	0.32
EPS (Diluted)	0.60	0.73	-0.15	0.50	0.28	-0.42
EPS Growth	113.36%	-	-	78.04%	-	-
Free Cash Flow	63.02	56.66	50.3	67.22	105.76	64.81
Free Cash Flow Per Share	2.52	2.24	1.71	2.16	3.40	1.75
Dividend Per Share	0.244	0.244	0.238	0.230	0.220	0.759
Dividend Growth	4.80%	2.48%	3.64%	4.46%	-71.04%	-7.97%
Gross Margin	36.93%	36.50%	36.10%	37.30%	35.29%	39.36%
Operating Margin	15.97%	15.06%	14.52%	16.12%	11.48%	16.77%
Profit Margin	3.57%	4.15%	-1.04%	3.89%	2.42%	2.47%
Free Cash Flow Margin	14.17%	12.72%	11.85%	16.86%	29.07%	16.28%
EBITDA	81.28	77.95	71.58	80.86	59.55	87.1
EBITDA Margin	18.28%	17.49%	16.86%	20.28%	16.37%	21.88%
D&A For EBITDA	10.27	10.84	9.93	16.6	17.77	20.35
EBIT	71.01	67.11	61.65	64.26	41.79	66.76
EBIT Margin	15.97%	15.06%	14.52%	16.12%	11.48%	16.77%
Effective Tax Rate	14.14%	15.91%	29.75%	8.64%	10.43%	16.78%
Revenue as Reported	444.59	445.58	414.39	411.73	389.86	398.1

Source: S&P Capital IQ. Standard template.